Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 21.80%329.39M | -13.42%992.97M | -25.79%201.55M | 1.56%311.24M | -24.08%225.48M | -0.54%270.44M | 2.69%1.15B | -2.77%271.59M | 39.19%306.46M | 0.85%297M |
| Cost of revenue | -31.34%111.9M | -16.85%620.04M | -30.54%142.06M | 3.11%173.48M | -28.15%150.54M | -0.26%162.97M | 0.17%745.69M | -5.25%204.52M | 75.74%168.25M | 11.23%209.53M |
| Gross profit | 102.38%217.49M | -7.06%372.94M | -11.31%59.49M | -0.33%137.76M | -14.32%74.94M | -0.96%107.47M | 7.73%401.26M | 5.67%67.07M | 11.07%138.21M | -17.57%87.47M |
| Operating expense | -18.51%19.26M | -18.49%97.47M | 3.37%27.66M | -8.94%22.9M | -31.66%22.66M | -31.50%23.64M | -8.52%119.57M | -27.90%26.76M | -35.00%25.14M | 7.49%33.16M |
| Selling and administrative expenses | -19.83%16.7M | -17.93%84.18M | 7.22%24.63M | -4.16%19.76M | -30.08%19.84M | -31.30%20.83M | -16.77%102.57M | -41.54%22.97M | -41.66%20.62M | 12.37%28.37M |
| -Selling and marketing expense | ---- | 8.13%4.4M | ---- | ---- | ---- | ---- | -51.88%4.07M | ---- | ---- | ---- |
| -General and administrative expense | -19.83%16.7M | -19.01%79.78M | 7.22%24.63M | -4.16%19.76M | -30.08%19.84M | -31.30%20.83M | -14.18%98.5M | -25.49%22.97M | -41.66%20.62M | 12.37%28.37M |
| Depreciation and amortization | -8.71%2.56M | -31.74%11.8M | -19.97%3.03M | -30.68%3.14M | -41.00%2.83M | -32.95%2.8M | --17.29M | --3.79M | 35.42%4.53M | -14.50%4.79M |
| -Depreciation | -8.71%2.56M | -31.74%11.8M | -19.97%3.03M | -30.68%3.14M | -41.00%2.83M | -32.95%2.8M | --17.29M | --3.79M | 35.42%4.53M | -14.50%4.79M |
| Other operating expenses | ---- | -21.85%13.28M | ---- | ---- | ---- | ---- | 127.90%17M | ---- | ---- | ---- |
| Operating profit | 136.46%198.23M | -2.21%275.47M | -21.05%31.83M | 1.59%114.86M | -3.74%52.28M | 13.29%83.83M | 16.51%281.69M | 52.92%40.31M | 31.85%113.06M | -27.85%54.31M |
| Net non-operating interest income (expenses) | -1.88%-111.31M | -16.51%-434.8M | 8.60%-102.6M | 1.76%-108.9M | -17.50%-110.77M | -90.99%-109.26M | -57.01%-373.21M | -81.98%-112.25M | -86.62%-110.85M | -57.17%-94.27M |
| Non-operating interest income | -83.66%565K | -14.32%6.53M | 361.49%4.7M | -23.25%954K | -66.17%702K | 80.24%3.46M | -14.03%7.63M | -68.16%1.02M | -41.64%1.24M | 10.84%2.08M |
| Non-operating interest expense | -0.74%111.88M | 16.47%418.6M | -5.27%107.3M | -2.00%109.85M | 15.70%111.47M | 90.64%112.72M | 58.53%359.39M | 151.60%113.27M | 82.18%112.09M | 55.77%96.35M |
| Total other finance cost | ---- | 6.05%22.74M | ---- | ---- | ---- | ---- | 7.93%21.44M | ---- | ---- | ---- |
| Net investment income | -94.05%73K | -57.43%1.23M | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 54.83%9.6M | -46.64%6.2M | ||||||||
| Income from associates and other participating interests | 5.66%-100K | -13.22%15.2M | -119.80%-1.95M | -6.31%6.96M | 756.73%10.29M | -105.89%-106K | 15,069.23%17.51M | 8,517.95%9.85M | 7.43M | -1.57M |
| Special income (charges) | 811.63%17.32M | 240.50%1.9M | ||||||||
| Less:Impairment of capital assets | ---- | -6.93%-771K | ---- | ---- | ---- | ---- | ---721K | ---- | ---- | ---- |
| Less:Other special charges | ---- | -1,303.73%-16.55M | ---- | ---- | ---- | ---- | -111.29%-1.18M | ---- | ---- | ---- |
| Other non-operating income (expenses) | -21.46%7.15M | 33.66%19.09M | -34.77%5.13M | 24.12%5.69M | 92.14%15.59M | 106.14%9.1M | 149.50%14.28M | 117.34%7.87M | -12.83%4.59M | 39.23%8.11M |
| Income before tax | 671.85%93.97M | -94.57%-98.05M | -24.65%-67.59M | 30.76%18.61M | 2.41%-32.61M | -171.42%-16.43M | -411.35%-50.39M | 17.56%-54.22M | -54.98%14.23M | -258.23%-33.41M |
| Income tax | 547.96%38.87M | -73.59%17.91M | -106.64%-1.24M | -76.38%2.67M | -41.35%10.22M | -70.54%6M | -31.82%67.81M | -63.52%18.72M | -73.34%11.32M | 368.83%17.42M |
| Net income | 345.62%55.1M | 1.90%-115.96M | 9.04%-66.35M | 446.45%15.94M | 15.75%-42.82M | -948.69%-22.43M | -8.13%-118.21M | 37.70%-72.94M | 126.94%2.92M | -392.08%-50.83M |
| Net income continuous operations | 345.62%55.1M | 1.90%-115.96M | 9.04%-66.35M | 446.45%15.94M | 15.75%-42.82M | -948.69%-22.43M | -8.13%-118.21M | 37.70%-72.94M | 126.94%2.92M | -392.08%-50.83M |
| Noncontrolling interests | 1,828.76%46.81M | 397.09%23.6M | 27.59%-5.84M | 83.16%25.69M | 271.95%1.32M | 651.59%2.43M | 165.05%4.75M | 62.31%-8.07M | 178.90%14.03M | -104.48%-770K |
| Net income attributable to the company | 133.33%8.28M | -13.50%-139.56M | 6.73%-60.5M | 12.23%-9.75M | 11.81%-44.15M | -906.29%-24.86M | -10.66%-122.96M | 32.19%-64.87M | 29.94%-11.11M | -22,548.88%-50.06M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 133.33%8.28M | -13.50%-139.56M | 6.73%-60.5M | 12.23%-9.75M | 11.81%-44.15M | -906.29%-24.86M | -10.66%-122.96M | 32.19%-64.87M | 29.94%-11.11M | -22,548.88%-50.06M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 133.33%0.0028 | -11.61%-0.0471 | 8.52%-0.0204 | 10.81%-0.0033 | 11.83%-0.0149 | -940.00%-0.0084 | -2.43%-0.0422 | 37.18%-0.0223 | 37.29%-0.0037 | -17,000.00%-0.0169 |
| Diluted earnings per share | 133.33%0.0028 | -11.61%-0.0471 | 8.52%-0.0204 | 10.81%-0.0033 | 11.83%-0.0149 | -940.00%-0.0084 | -2.43%-0.0422 | 37.18%-0.0223 | 37.29%-0.0037 | -17,000.00%-0.0169 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.